© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 7, 540-547,
April 2, 2003
© 2003 Oxford University Press
ARTICLE |
Genetic Instability in Bladder Cancer Assessed by the Comet Assay
Affiliation of authors: M. B. Schabath, M. R. Spitz, K. Zhang, P.-J. Zheng, X. Wu (Department of Epidemiology), H. B. Grossman, C. P. Dinney (Department of Urology), The University of Texas M. D. Anderson Cancer Center, Houston, TX.
Correspondence to: Xifeng Wu, M.D., Ph.D., The University of Texas M. D. Anderson Cancer Center, Department of Epidemiology, Box 189, 1515 Holcombe Blvd., Houston, TX 77030 (e-mail: xwu{at}mdanderson.org).
Background: Latent genetic instability has been associated with an increased risk for several cancers. We used the comet assay (single-cell gel electrophoresis) to assess whether genetic instability, as reflected by susceptibility to DNA damage, was associated with the risk of bladder cancer in a case–control study. Methods: We used the comet assay to measure baseline and benzo[a]pyrene diol epoxide (BPDE)- and 
-radiation-induced DNA damage in individual peripheral blood lymphocytes from 114 incident case patients with bladder cancer and 145 matched healthy control subjects. All subjects provided personal information, including smoking history. DNA damage was visualized with the comet assay and quantified by the Olive tail moment parameter, a relative measure. Multivariable analysis was used to assess relative risks for bladder cancer associated with DNA damage. All statistical tests were two-sided. Results: Baseline levels of DNA damage were statistically significantly higher in case patients (tail moment = 1.40) than in control subjects (tail moment = 1.21) (difference = 0.19, 95% confidence interval [CI] = 0.04 to 0.32; P = .015), as were -radiation-induced (tail moment = 4.76 versus 4.22; difference = 0.54, 95% CI = 0.11 to 0.96; P = .013) and BPDE-induced (tail moment = 4.06 versus 3.45; difference = 0.61, 95% CI = 0.23 to 0.99; P = .002) DNA damage. When data were dichotomized at the median value for DNA damage in control subjects and adjusted for age, sex, ethnicity, and smoking status, an increased estimated relative risk of bladder cancer was statistically significantly associated with DNA damage at baseline (odds ratio [OR] = 1.84, 95% CI = 1.07 to 3.15) and after -radiation (OR = 1.81, 95% CI = 1.04 to 3.14) but not after BPDE treatment (OR = 1.69, 95% CI = 0.98 to 2.93). Conclusion: Latent genetic instability as measured by the comet assay is associated with an increased estimated relative risk of bladder cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Gu, Y. Horikawa, M. Chen, C. P. Dinney, and X. Wu Benzo(a)pyrene Diol Epoxide-Induced Chromosome 9p21 Aberrations Are Associated with Increased Risk of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2445 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bhatti, A. J. Sigurdson, C. B. Thomas, A. Iwan, B. H. Alexander, D. Kampa, L. Bowen, M. M. Doody, and I. M. Jones No Evidence for Differences in DNA Damage Assessed before and after a Cancer Diagnosis Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 990 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al. Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xing, Y. Zhu, H. Zhao, H. Yang, M. Chen, M. R. Spitz, and X. Wu Differential Induction in Telomerase Activity among Bladder Cancer Patients and Controls on {gamma}-Radiation Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 606 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Rothman, M. Garcia-Closas, and D. W Hein Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned Int. J. Epidemiol., February 1, 2007; 36(1): 23 - 28. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. El-Zein, M. B. Schabath, C. J. Etzel, M. S. Lopez, J. D. Franklin, and M. R. Spitz Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res., June 15, 2006; 66(12): 6449 - 6456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hoffmann, J. Hogel, and G. Speit The effect of smoking on DNA effects in the comet assay: a meta-analysis Mutagenesis, November 1, 2005; 20(6): 455 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, F. F. Kadlubar, M. R. Spitz, H. Zhao, and X. Wu A Modified Host Cell Reactivation Assay to Measure DNA Repair Capacity for Removing 4-Aminobiphenyl Adducts: A Pilot Study of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1832 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, J. A. Roth, H. Zhao, S. Luo, Y.-L. Zheng, S. Chiang, and M. R. Spitz Cell Cycle Checkpoints, DNA Damage/Repair, and Lung Cancer Risk Cancer Res., January 1, 2005; 65(1): 349 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Schabath, H. B. Grossman, G. L. Delclos, L. M. Hernandez, R. S. Day, B. R. Davis, S. P. Lerner, M. R. Spitz, and X. Wu Dietary Carotenoids and Genetic Instability Modify Bladder Cancer Risk J. Nutr., December 1, 2004; 134(12): 3362 - 3369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Berman, Y. Wang, Z. Liu, Q. Dong, L.-A. Burke, L. A. Liotta, R. Fisher, and X. Wu A Functional Polymorphism in RGS6 Modulates the Risk of Bladder Cancer Cancer Res., September 15, 2004; 64(18): 6820 - 6826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lee, E. Oh, J. Lee, D. Sul, and J. Lee Use of the Tail Moment of the Lymphocytes to Evaluate DNA Damage in Human Biomonitoring Studies Toxicol. Sci., September 1, 2004; 81(1): 121 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Spitz, Q. Wei, Q. Dong, C. I. Amos, and X. Wu Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 689 - 698. [Full Text] [PDF]
|
|